The impact of age and comorbidities on practice patterns and outcomes in patients with relapsed/refractory multiple myeloma in the era of novel therapies-Reference-Cited by-同舟云学术

The impact of age and comorbidities on practice patterns and outcomes in patients with relapsed/refractory multiple myeloma in the era of novel therapies

Published:2018-03 Issue:2 Volume:9 Page:138-144
ISSN:1879-4068
Container-title:Journal of Geriatric Oncology
language:en
Short-container-title:Journal of Geriatric Oncology

Author:

Hari Parameswaran,Romanus Dorothy,Luptakova Katarina,Blazer Marlo,Yong Candice,Raju Aditya,Farrelly Eileen,Labotka Richard,Morrison Vicki A.

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Oncology

Reference32 articles.

1. Clinical course of patients with relapsed multiple myeloma;Kumar;Mayo Clin Proc,2004

2. Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution;Bladé;Arch Intern Med,1998

3. Renal function in newly diagnosed multiple myeloma--a demographic study of 1353 patients. The Nordic Myeloma Study Group;Knudsen;Eur J Haematol,1994

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current progress in CAR-based therapy for kidney disease;Frontiers in Immunology;2024-08-20

2. The Role of Monoclonal Antibodies in the Treatment of Myeloma Kidney Disease;Pharmaceuticals;2024-08-05

3. Patient-reported frailty phenotype (PRFP) vs. International Myeloma Working Group frailty index (IMWG FI) proxy: A comparison between two approaches to measuring frailty;Journal of Geriatric Oncology;2024-03

4. Impact of elranatamab on quality of life: Patient‐reported outcomes from MagnetisMM‐3;British Journal of Haematology;2024-02-29

5. Difficult‐to‐treat patients with relapsed/refractory multiple myeloma: A review of clinical trial results;eJHaem;2023-08-02